VR-54

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameVR-54
Drug Alias NameVR-54
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A